|
Re: Zenith Q4 2017 Events
|
3
|
Zenith Epigenetics
|
Nov 13, 2017 10:30AM
|
|
Re: CANTOS and CIRT
|
7
|
Resverlogix Corp.
|
Nov 13, 2017 04:44PM
|
|
Re: American Heart Association 2017
|
3
|
Resverlogix Corp.
|
Nov 13, 2017 05:24PM
|
|
Re: CANTOS and CIRT
|
4
|
Resverlogix Corp.
|
Nov 14, 2017 12:32PM
|
|
Re: Zenith share issue
|
2
|
Zenith Epigenetics
|
Nov 14, 2017 12:34PM
|
|
Re: Zenith share issue
|
7
|
Zenith Epigenetics
|
Nov 14, 2017 12:47PM
|
|
Re: CANTOS and CIRT
|
4
|
Resverlogix Corp.
|
Nov 14, 2017 03:51PM
|
|
Re: BioSpace-Amgen's Repatha
|
7
|
Resverlogix Corp.
|
Nov 15, 2017 11:13PM
|
|
Re: The Prescription
|
2
|
Resverlogix Corp.
|
Nov 16, 2017 10:18AM
|
|
Re: BioSpace-Amgen's Repatha
|
4
|
Resverlogix Corp.
|
Nov 16, 2017 10:43AM
|
|
Re: The Prescription
|
6
|
Resverlogix Corp.
|
Nov 16, 2017 11:10AM
|
|
Sangamo In Vivo Gene Editing for Enzyme/Protein Replacement Therapy
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 17, 2017 10:42AM
|
|
Re: 2% market penetration
|
6
|
Resverlogix Corp.
|
Nov 17, 2017 05:25PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
6
|
Zenith Epigenetics
|
Nov 18, 2017 06:46PM
|
|
Bioasis on Beacon Securities watch list
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2017 01:27PM
|
|
New Video on Perception and Memory
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2017 01:32PM
|
|
BETonMACE USA vs. non-USA brainstorming
|
3
|
Resverlogix Corp.
|
Nov 20, 2017 05:40PM
|
|
Re: BETonMACE USA vs. non-USA brainstorming
|
3
|
Resverlogix Corp.
|
Nov 20, 2017 07:16PM
|
|
Re: BETonMACE USA vs. non-USA brainstorming
|
10
|
Resverlogix Corp.
|
Nov 20, 2017 08:16PM
|
|
Re: I still haven't gotten anything in the mail....
|
3
|
Resverlogix Corp.
|
Nov 20, 2017 10:31PM
|
